Plasmidsaurus has introduced an innovative RNA-Seq service specifically designed for Illumina short read applications, streamlining the process of gene expression analysis. This launch, presented at the ASHG annual conference in Boston, aims to enhance the efficiency of transcriptomics, allowing researchers to obtain detailed insights without extended delays.
During the conference, attendees had the opportunity to engage with Plasmidsaurus scientists and preview the new intuitive RNA-Seq analytics tools. According to Mark Budde, co-founder and CEO of Plasmidsaurus, “Getting good transcriptomics data shouldn’t take weeks of hassle. Send us cells and we’ll get you answers.” The service promises to significantly reduce turnaround times for RNA expression profiling, with preliminary results available in as little as three days.
The new RNA-Seq offering accepts crude cell preparations and allows cultured cells to be submitted in Zymo DNA/RNA Shield at ambient temperature through a network of drop-boxes. This user-friendly approach eliminates the need for a dedicated bioinformatician, empowering customers to independently create and analyze their gene expression experiments directly on the results page.
Molly Gasperini, associate director of genome engineering at the Allen Institute, praised the service, stating, “Huge kudos to Plasmidsaurus for this incredibly fast, affordable service.” Early access users like Gasperini have expressed enthusiasm about the speed and accessibility of the new RNA-Seq tools.
Plasmidsaurus co-founder and CTO Jim Stapleton highlighted the broader implications of the service for various sectors. He noted that pharmaceutical and biotech companies could leverage this rapid feedback system for drug candidate evaluation and genome editing. The service also suits any researcher needing quick validation of cell line identity and health.
The launch of the RNA-Seq service follows several recent developments at Plasmidsaurus, including the introduction of overnight microbiome amplicon sequencing to expedite microbiology research and a fast, low-input adeno-associated virus (AAV) genome sequencing service aimed at accelerating gene therapy research and development. Additionally, the company has recently inaugurated its tenth global sequencing lab in Singapore.
As the field of genomics continues to evolve, Plasmidsaurus remains committed to providing cutting-edge solutions that facilitate rapid scientific advancements. The team is eager to see how researchers will utilize these innovative RNA-Seq capabilities to explore new applications and enhance their workflows. The company’s ongoing dedication to improving sequencing services promises to contribute significantly to the acceleration of scientific discovery.
